GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (FRA:PDXN) » Definitions » YoY EBITDA Growth

Pro-Dex (FRA:PDXN) YoY EBITDA Growth : 2.08% (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pro-Dex YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Pro-Dex's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 2.08%.

Pro-Dex's EBITDA per Share for the three months ended in Jun. 2024 was €0.64.

Pro-Dex YoY EBITDA Growth Historical Data

The historical data trend for Pro-Dex's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro-Dex YoY EBITDA Growth Chart

Pro-Dex Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 50.91 -3.80 -5.15 58.58 -58.76

Pro-Dex Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.22 -122.24 -74.83 -46.47 2.08

Pro-Dex YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Pro-Dex's YoY EBITDA Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (A: Jun. 2024 )
=(EBITDA per Share (A: Jun. 2024 )-EBITDA per Share (A: Jun. 2023 ))/ | EBITDA per Share (A: Jun. 2023 ) |
=(1.132-2.745)/ | 2.745 |
=-58.76 %

Pro-Dex's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

YoY EBITDA Growth (Q: Jun. 2024 )
=(EBITDA per Share (Q: Jun. 2024 )-EBITDA per Share (Q: Jun. 2023 )) / | EBITDA per Share (Q: Jun. 2023 )) |
=(0.638-0.625)/ | 0.625 |
=2.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro-Dex YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Pro-Dex's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro-Dex Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pro-Dex Inc (FRA:PDXN) » Definitions » YoY EBITDA Growth
Comparable Companies
MLSS BNGO UEEC DXR KRMD POCI RVP YBGJ FEMY EKSO ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD OCSE:COLO B TSE:4543 XSWX:STMN WST
Traded in Other Exchanges
PDEX:USA
Address
2361 McGaw Avenue, Irvine, CA, USA, 92614
Website
https://www.pro-dex.com
Pro-Dex Inc is engaged in designing, developing, and manufacturing powered rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. In addition, the company provides engineering consulting and placement services, as well as quality and regulatory consulting services. Most of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Pro-Dex Headlines

No Headlines